Session » Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

Date: Monday, November 9, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 1869

“Rheum to Diagnosis”: Uncovering Impediments to Accurate Diagnosis of Non-radiographic Axial Spondylarthritis (nr-axSpA)

9:00AM-11:00AM: Abstract Number: 1882

Are There Any Clues to Predict Bamboo Spine in Axial Spondyloarthritis?

9:00AM-11:00AM: Abstract Number: 1903

Assessment of Global DNA Methylation in Peripheral Blood Cell Subpopulations of Patients with Axial Spondyloarthritis : Preliminary Results

9:00AM-11:00AM: Abstract Number: 1880

Association of Healthcare Utilization and Costs with Patient-Reported Outcomes in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1901

Clinical Characteristics of Importance to Outcome in Patients with Axial Spondyloarthritis: A Prospective Cohort Study

9:00AM-11:00AM: Abstract Number: 1904

Clinical Features of Patients with Active Ankylosing Spondylitis Who Did Not Respond to Adalimumab but Responded to Ixekizumab: A Post-hoc Analysis

9:00AM-11:00AM: Abstract Number: 1863

Clinical History as Tool for Diagnosis and Classification of Patients with Ankylosing Spondylitis (Axial Spondyloarthritis): Evidence from a 35-Year Follow-up Family Study of a Swiss Cohort

9:00AM-11:00AM: Abstract Number: 1898

Comparative Effectiveness of Secukinumab, Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1868

Comparison of Quality of Life Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-up: Data from the Spondyloarthritis Caught Early Cohort

9:00AM-11:00AM: Abstract Number: 1871

Comparison of Work Productivity Outcomes Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-Up: Data from the Spondyloarthritis Caught Early Cohort

9:00AM-11:00AM: Abstract Number: 1878

Consensus Definitions for MRI Lesions in the Spine of Patients with Axial Spondyloarthritis: First Analysis from the Assessments in SpondyloArthritis International Society Classification Cohort

9:00AM-11:00AM: Abstract Number: 1890

Daily Management of Patients with Axial Spondyloarthritis: Self-monitoring of Disease Activity with a Smartphone App Is Feasible – a Proof of Concept Study

9:00AM-11:00AM: Abstract Number: 1902

Determinants of Physician Global Assessment and Influence of Contextual Factors in Early Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1879

Development of a Deep Learning Algorithm to Predict Positive MRI of the Sacroiliac Joints According to the ASAS Definition in Patients with Recent Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1870

Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration

9:00AM-11:00AM: Abstract Number: 1877

Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI

9:00AM-11:00AM: Abstract Number: 1874

Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1884

Disease Activity in an Axial Spondyloarthritis Cohort During the COVID-19 Pandemic

9:00AM-11:00AM: Abstract Number: 1883

Exercise Partially Explains the Impact of Body Mass Index on Disease Activity in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1862

Genetic Influences on Occurrence of Axial Spondyloarthritis (axSpA) in First-degree Relatives During a Prospective Study Lasting 35 Years

9:00AM-11:00AM: Abstract Number: 1875

Heterogeneity Amongst Men and Women with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1864

How to Diagnose Axial Spondyloarthritis in 2020? A Data-Driven Estimation of the Disease Probability in Patients with a priori Different Likelihoods of the Diagnosis

9:00AM-11:00AM: Abstract Number: 1865

Identification of Parameters Associated with a Diagnostic Delay in Axial Spondyloarthritis:Results from the European Map of Axial Spondyloarthritis (EMAS)

9:00AM-11:00AM: Abstract Number: 1891

Impact of Utilising Smart Phone Application in Ankylosing Spondylitis: SMART- as Study

9:00AM-11:00AM: Abstract Number: 1881

In Radiographic Axial Spondyloarthritis, Bridging Syndesmophytes Increase Risk of Facet Joint Ankylosis Development on the Same Vertebral Level While Facet Joint Ankylosis Does Not Increase Risk of Same Level Syndesmophytes Development

9:00AM-11:00AM: Abstract Number: 1899

Life Expectancy a Swiss Cohort of Patients with Ankylosing Spondylitis: A 35-Year Follow-up Study

9:00AM-11:00AM: Abstract Number: 1886

Measuring Physical Activity in AxSpA:Content Validity and Measurement Properties of the New AxSpA-SQUASH

9:00AM-11:00AM: Abstract Number: 1896

No Relationship Between Lumbar Bone Mineral Density and Syndesmophyte Formation at the Same Level – A Multilevel Analysis in Patients with Radiographic Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1866

Patient-reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas 2017

9:00AM-11:00AM: Abstract Number: 1892

Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for F Ankylosing Spondylitis (AS) Patients with the App of Smart System of Disease Management (SSDM): A Cohort Study from China

9:00AM-11:00AM: Abstract Number: 1885

Performance of SASDAS (Simplified Axial Spondyloarthritis Disease Activity Score) versus ASDAS in a Post Hoc Analysis of a Randomized Controlled Clinical Trial

9:00AM-11:00AM: Abstract Number: 1893

Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses

9:00AM-11:00AM: Abstract Number: 1895

Radiographic Progression in Patients with Axial Spondyloarthritis Under Treatment with TNF Inhibitors. Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides)

9:00AM-11:00AM: Abstract Number: 1872

Relative Associations of Sociodemographic, Clinical and HLA-B Alleles with Enthesitis and Peripheral Arthritis in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1889

Reliability and Validity of the PROMIS-29 Health Profile in Ankylosing Spondylitis Patients

9:00AM-11:00AM: Abstract Number: 1887

Spinal Mobility and Function: How Closely Do They Associate in Axial Spondyloarthropathy?

9:00AM-11:00AM: Abstract Number: 1888

Successful Evaluation of Spinal Mobility Measurements with the Epionics SPINE Device in Patients with Axial Spondyloarthritis Compared to Controls

9:00AM-11:00AM: Abstract Number: 1873

The Changing Profile of Ankylosing Spondylitis in the Biologic Era

9:00AM-11:00AM: Abstract Number: 1900

The Clinical and the Functional Impact of Central Sensitization on Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1876

The Role of HLA B27 in Axial Spondyloarthritis: Prevalence and Performance as a Marker in an Argentinian Cohort

9:00AM-11:00AM: Abstract Number: 1897

Trends in Hospitalizations for Vertebral Compression Fractures in Ankylosing Spondylitis: Data from the National Inpatient Sample 2001-2014

9:00AM-11:00AM: Abstract Number: 1867

Two-Year Diagnostic Consistency in Patients with Chronic Back Pain Suspected of Axial Spondyloarthritis in Protocolised Follow-up: Data from the Spondyloarthritis Caught Early Cohort

9:00AM-11:00AM: Abstract Number: 1894

Use of Facebook and Electronic Patient Portal to Identify Axial Spondyloarthritis in Patients with Chronic Back Pain

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].